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Background: Ras proteins are critical regulators of cellular
growth and are differentially modified by ubiquitination.
Results: Chemical ubiquitination and immunoprecipita-
tion assays demonstrate that monoubiquitination causes
sustained H-Ras activation in the absence of oncogenic
mutations.
Conclusion:Themechanism bywhichH-Ras is activated
by monoubiquitination is both isoform-specific and
site-specific.
Significance:Monoubiquitination adds a new level of reg-
ulation and complexity to isoform-specific Ras signaling.
Ras GTPases are signaling switches that control critical cellu-
lar processes including gene expression, differentiation, and
apoptosis. The major Ras isoforms (K, H, and N) contain a con-
served core GTPase domain, but have distinct biological func-
tions. Among the three Ras isoforms there are clear differences
in post-translational regulation, which contribute to differences
in localization and signaling output. Modification by ubiquiti-
nation was recently reported to activate Ras signaling in cells,
but themechanisms of activation are not well understood.Here,
we show thatH-Ras is activated bymonoubiquitination and that
ubiquitination at Lys-117 accelerates intrinsic nucleotide
exchange, thereby promoting GTP loading. This mechanism of
Ras activation is distinct from K-Ras monoubiquitination at
Lys-147, which leads to impaired regulator-mediated GTP
hydrolysis. These findings reveal that different Ras isoforms are
monoubiquitinated at distinct sites, with distinct mechanisms
of action, but with a common ability to chronically activate
the protein in the absence of a receptor signal or oncogenic
mutation.
The small GTPase Ras is a signaling switch that regulates
cellular growth and differentiation (1). In accord with its essen-
tial role in regulating cell growth, point mutations in Ras are
common in cancer; about 30% of all human tumors contain an
activating Ras mutation (2). To control the activation of essen-
tial pathways involved in cell proliferation, differentiation, and
apoptosis, Ras binds and hydrolyzes GTP. Ras is active when it
is GTP-bound and becomes inactive when GTP is hydrolyzed
to GDP (3, 4). On its own, Ras is a poor enzyme and requires
regulators to respond to cell signals on an appropriate times-
cale. The primary regulators of Ras cycling are guanine nucle-
otide exchange factors (GEFs),4 which increase the rate of GDP
dissociation and GTP loading, leading to Ras activation (5, 6),
and GTPase-activating proteins (GAPs), which down-regulate
activated Ras by increasing the rate of GTP hydrolysis (4, 7).
There are three isoforms of Ras: K-Ras (two splice variants,
K-Ras4A and K-Ras4B), H-Ras, and N-Ras. The core guanine
nucleotide binding domain is highly conserved between these
isoforms (90% identical in the first 168 amino acids). How-
ever, despite the high sequence identity, Ras isoforms play dis-
tinct roles in regulating downstream signaling pathways. In
particular, the three proteins exhibit differences in their local-
ization in vivo, which alters access to regulatory proteins and
downstream effectors (8–10). H-Ras andN-Ras are localized at
both the plasma membrane and the Golgi, whereas K-Ras is
predominately at the plasmamembrane (11). Differences in Ras
localization and activity are driven by differences in post-trans-
lational modifications (12–19). For example, differential lipida-
tion of the Ras isoforms within their variable C-terminal
domain is essential for proper membrane targeting and local-
ization, which is in turn necessary for proper signaling (15,
20–24). Another post-translational modification, phosphoryl-
ation, has been shown to modulate K-Ras signaling output by
changing its localization from the plasma membrane to the
mitochondria and Golgi (25). Both lipid and phosphoryl mod-
ifications are dynamically regulated, which in turn dynamically
controls Ras localization and activity (25).
Aside from lipidation and phosphorylation, there is mount-
ing evidence that ubiquitination also contributes to the differ-
entiation between Ras isoforms (26). Ubiquitination of an as yet
unidentified site in H-Ras promotes its association with the
endosome (26, 27). This localization change leads to altered
effector interactions and signaling output (25). We and others
have shown that monoubiquitination of Lys-147 in K-Ras does
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not appear to affect protein localization, but rather acts as a
reversible trigger for signal initiation (28, 29).Monoubiquitina-
tion of K-Ras at this position impedes GAP-mediated GTP
hydrolysis and promotes association with select downstream
effectors (28, 29). This mechanism of K-Ras activation appears
specific to ubiquitination at Lys-147 because modification of
other lysines does not confer a GAP defect (29). Thus, H-Ras
and K-Ras display differential regulation by ubiquitination.
In addition to Lys-147, Sasaki et al. (28) have identified Lys-
117 as a site of ubiquitination in H-Ras and Lys-104 as a sec-
ondary site of ubiquitination in K-Ras. Thus, we postulated that
different sites ofH- andK-Ras ubiquitination have distinct con-
sequences for Ras activity. Here, we show that monoubiquiti-
nation at Lys-104 does not affect nucleotide exchange or
hydrolysis properties of Ras, whereas modification at Lys-117
promotes Ras activation. However, in this case, the mechanism
of activation is unique. Althoughmonoubiquitination of K-Ras
at Lys-147 inhibitsGAP-mediated hydrolysis,monoubiquitina-
tion of H-Ras at Lys-117 greatly enhances GTP-GDP exchange.
These findings reveal that K-Ras and H-Ras can each be acti-
vated bymonoubiquitination, but that activation occurs via dis-
tinct molecular mechanisms.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—All Ras constructs
were generated with a C118S mutation to eliminate a native
solvent exposed cysteine, as described previously (29, 30).
The Ras domains (1–166) of H-RasC118S, H-RasC118S/K104C,
and H-RasC118S/K117C were expressed and purified as described
previously (29). The standard Ras protocol was revised for puri-
fication of H-RasC118S/K117C by the addition of 10% glycerol to
all buffers to accommodate for the instability of this variant.
Catalytic domains of the GEF, Sos (Soscat), and GAP, p120GAP
(GAP-334), were purified as described previously (29, 31). Full-
lengthubiquitinG76Cwasalsopurifiedasdescribedpreviously (29).
Chemical Ubiquitination—The chemical ligation strategy
used to link H-RasK104C and H-RasK117C to ubiquitinG76C was
performed essentially as described in Baker et al. (29), except
that 10% glycerol was added to buffers containing the RasK117C
variant.
Thermal Stability of Ras—The fast quantitative cysteine
reactivity (fQCR) method (32) was employed to measure
changes in Ras thermal stability. Briefly, 2 M RasK104C,
mUbRasK104, RasK117C, or mUbRasK117 was incubated with 1
mM 4-fluoro-7-aminosulfonylbenzofurazan (AnaSpec) at pH
7.0 in the presence of 20 M GTPS and 2 mM MgCl2 in a
gradient thermocycler (Biometra TProfessional thermocycler)
at the desired temperature for 3 min. Reactions were quenched
by the addition of 0.02 N HCl (final concentration). Fluores-
cence intensity was measured on a PHERAstar plate reader
(BMG Labtech) with excitation and emission band-pass filters
of 400 and 500 nm. The highest fluorescence for each unfolding
curve was normalized to one after base lines were corrected for
differences in background fluorescence. Data were fit using
GraphPad Prism (GraphPad Software; SanDiego, CA) to deter-
mine the melting temperature (Tm) for each construct.
NucleotideDissociationAssay—FortheRasK104CandmUbRasK104
variants, the N-methylanthraniloyl (MANT)-GDP nucleotide
dissociation assay was performed as described previously (29).
The assaywas adapted for RasK117C andmUbRasK117 as follows.
Ras protein was exchanged into MANT nucleotide exchange
buffer (50 mM Tris, pH 8.0, 50 mM NaCl, and 5 mM MgCl2).
MANT-GDP (0.5 M) was added to 1 M of protein in the
cuvette. The Ras protein was determined to be fully loaded when
the fluorescence of the spectra no longer increased,500 s. Unla-
beledGDP (final concentration of 100M)was added to initiate
dissociation. Soscat was mixed with H-Ras at a 1:1 molar ratio.
MANT-GDP dissociation wasmeasured as a change in fluores-
cence intensity over time (excitation: 360 nm, emission: 440
nm) (LS50B PerkinElmer luminescence spectrometer). Fluo-
rescence data were fit in GraphPad Prism to a one-phase expo-
nential decay curve to determine rates of nucleotide release.
Single Turnover Nucleotide Hydrolysis—Single turnover nucle-
otide hydrolysis assays were performed as described in Baker et
al. (29). The ratio of fluorescence emissionwasmeasured at 480
and 530 nm with an excitation of 435 nm on a SpectraMax M5
(Molecular Devices). Fluorescence ratios were converted to
phosphate concentrations using a standard curve. The meas-
ured rates of phosphate release over time were fit in GraphPad
Prism to a one-phase exponential association curve.
Multiple Turnover Nucleotide Hydrolysis—Due to limita-
tions associated with instability of RasK117C and mUbRasK117,
GTP hydrolysis was measured in the presence of excess GTP
(multiple turnover). Ras was exchanged (20-fold dilution and
concentrated three times) into phosphate-free buffer with 5
mM EDTA. For intrinsic hydrolysis, 20 M Ras was mixed with
60 M GTP, and hydrolysis was initiated by the addition of
magnesium. For GAP-mediated hydrolysis, GAP-334, at con-
centrations ranging from 0.0625 to 8 M, was added to the
reaction. The phosphate-binding protein Flippi 5U (Addgene)
was used to detect inorganic phosphate released upon GTP
hydrolysis (33). Fluorescence emission was measured as a ratio
at 480 and 530 nm and an excitation of 435 nm (SpectraMax
M5,Molecular Devices). Fluorescence ratios were converted to
a phosphate concentration using a standard curve. Data from
the first 10 min of hydrolysis were fit in GraphPad Prism to a
linear regression and the resulting rates were plotted as a func-
tion of GAP concentration.
Mapping GEF and GAP Binding Sites on Ras—The pHinder
algorithm was used to calculate a surface between Ras and the
catalytic domains of Sos and p120GAP. Information on the tri-
angulation used to define the surface has been described else-
where (34). Residues were considered to be part of the interac-
tion surface if theywere less than 6Å apart. Interaction surfaces
were determined from the crystal structures of Ras with Sos
(Protein Data Bank (PDB) 1BKD) and Ras with p120GAP (PDB
1WQ1).
Assays inCellLysate—Rasactivationwasmeasuredasdescribed
previously (28). The constructs FLAG-His-H-Ras or the
mutant FLAG-His-H-RasK117N were co-expressed with
HA-ubiquitin in HEK293T cells. The cells were prepared and
lysed as described previously (29). For assays conducted in the
presence of either Soscat or p120GAP, the catalytic domainswere
purified from bacterially produced protein and incubated with
the cell lysate for 20min at room temperature. The effect of the
regulators on the population of active Ras or mUbRas was
REPORT: Monoubiquitination Differentially Activates Ras
DECEMBER 27, 2013 • VOLUME 288 • NUMBER 52 JOURNAL OF BIOLOGICAL CHEMISTRY 36857
assessed by immunoblotting using GST-Raf-RBD (Ras binding
domain) to detect active Ras. For the Soscat assay, 25 M of
GTPS was added during the incubation. Samples were pre-
pared from SDS-PAGE gels (Invitrogen, NuPAGE), and Ras
was detected by varying exposure times.
RESULTS
Monoubiquitination at Lys-117 Activates H-Ras by Increas-
ing Intrinsic Exchange—It was recently shown that H-Ras can
be monoubiquitinated at Lys-117 (28). Lysine 117 is part of the
conserved NKXD motif that contributes to nucleotide affinity
and specificity by forming interactions with the guanine nucleo-
tide base and ribose (Fig. 1A) (35). Conservativemutations at Lys-
117 (K117R andK117N) are present in human cancers and devel-
opmental disorders and lead to Ras activation by reducing
nucleotide binding affinity, resulting in increased rates of nucleo-
tide exchange (36–38). Given these observations, we postulated
that ubiquitination of Lys-117 is likely to disrupt interactions
between the lysine and the guanine nucleotide base and activate
Ras by amechanism similar to mutation at the same site.
We chemically ubiquitinatedRas at position 117 (mUbRasK117)
using a cysteine ligation approach reported by us previously (Fig.
1B) (29). Mutation at a nearby site in the conserved NKXDmotif,
Asp-119, reduces protein stability and increases the rate of nucle-
otide exchange (39).We therefore investigatedwhether perturba-
tions atLys-117couldalso alterprotein stability.Wemeasured the
thermal stabilityofRasusing the fQCRassay (32).Thisassaymeas-
ures protein unfolding as a function of temperature and chemical
labeling of exposed cysteines. Because ubiquitin does not contain
native cysteines, fQCR can be used to specifically determine
whether ubiquitination affects Ras thermal stability. We found
that mUbRasK117 retains the thermal stability observed for
unmodifiedRas (Fig. 1C) (Tm52.50.5 °C).However, ubiquiti-
nationatLys-117 isdistinct fromaRasK117Cmutation,which leads
to a 10° decrease in the thermal stability of Ras (RasK117C Tm 
43.8  0.9 °C). Relative to unmodified Ras, RasK117C and
mUbRasK117C exhibited less cooperative unfolding transitions
(Fig. 1C) and increased rates of nucleotide dissociation (Fig. 1D).
We attribute this correlation to loss of a key interaction (Lys-
117) that impairs nucleotide binding, resulting in reduced
cooperativity of the unfolding transition (40). Although
either ubiquitination or mutation of Ras at position 117
alters the lysine side chain, which is crucial for forming inter-
actions with the guanine nucleotide, these distinct altera-
tions differentially affect the thermal stability of Ras.
FIGURE 1. Monoubiquitination at lysine 117 activates H-Ras. A, graphic highlighting interactions formed between the NKXD motif of Ras (GDP) and the
guanine nucleotide base (PDB 1CRR). Nucleotide is color-coded by element (nitrogen in blue, oxygen in red, and carbon in green), and Lys-117 of Ras is shown
in purple. B, formation of disulfide bond between ubiquitinG76C and RasK117C under nonreducing (NR) and reducing (R) conditions. The product of the reaction
contains mUbRas, Ras, ubiquitin-ubiquitin dimer (Ub-Ub), and free ubiquitin (Ub). C, the thermal stability of Ras (black squares throughout), RasK117C (purple
triangles throughout), and mUbRasK117 (blue circles throughout) measured by fQCR. The data were normalized using the maximum fluorescence intensity.
Results are the mean  S.E. (n  4). D, intrinsic nucleotide release (closed symbols) for Ras, RasK117C, and mUbRasK117 bound to MANT-GDP. The rate of GDP
dissociation was determined by monitoring the decrease in MANT-GDP fluorescence emission over time following the addition of unlabeled GDP. Nucleotide
dissociation was also measured in the presence of a 1:1 molar ratio of Ras to Soscat (open symbols). Data were fit to an exponential dissociation curve, and the
results are the mean  S.E. (n  4). E, multi-turnover hydrolysis for Ras, RasK117C, and mUbRasK117. GTP hydrolysis was measured by monitoring the change in
fluorescence of the phosphate-binding protein, Flippi, upon binding to free phosphate. Data were converted to a phosphate concentration using a standard
curve. Phosphate release was measured for 20 M Ras in the presence of GAP concentrations ranging from 0.0625 to 8 M. Results are the mean  S.E. (n  4).
Data were fit to a one site binding model in GraphPad Prism.
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We next measured the effect of monoubiquitination on the
rate of guanine nucleotide dissociation.We find that the intrin-
sic rate of nucleotide dissociation was 70-fold faster for
mUbRasK117 as compared with unmodified Ras (8.3  0.3 
103 s1) (Fig. 1D). This finding is consistent with the 100-fold
increased rate of nucleotide release observed when Ras is
mutated (RasK117C) at this same position (11.0  0.4  101
s1) (Fig. 1D). We also observed a small increase in GDP disso-
ciation formUbRasK117 in the presence of the GEF, Soscat, indi-
cating that the nucleotide release can be further stimulated by
GEFs. Even in the absence of GEF-mediated activation, the
increased rate of intrinsic nucleotide dissociation should be suf-
ficient to promote GTP exchange and mUbRasK117 activation
in vivo (41).
We then measured intrinsic and GAP-mediated GTP
hydrolysis using a multi-turnover GTP hydrolysis assay, as
described previously (41). When Ras is monoubiquitinated at
Lys-117, the rate of intrinsic GTP hydrolysis is similar (within
2-fold) to that of unmodified Ras (Fig. 1E). Furthermore,
mUbRasK117 retains sensitivity to p120GAP (GAP-334), albeit
with a reduced binding affinity. As seen in Fig. 1E, at 8 M
GAP-334 (5:2 ratio of Ras to GAP-334), the rate of GTP hydrol-
ysis is not affected by monoubiquitination (0.024  0.003 and
0.023  0.002 s1 for Ras and mUbRasK117, respectively).
Therefore, mUbRasK117 is still sensitive to GAP-mediated
down-regulation. Similar results were observed for both
RasK117C (Fig. 1E) and RasK117R variants (41). Taken together,
these data demonstrate that monoubiquitination of H-Ras at
Lys-117 causes activation by enhancing the rate of nucleotide
exchange.
Ras Monoubiquitinated at Lys-104 Retains the Activity of
Unmodified Ras—Mass spectrometry characterization of
K-Ras and H-Ras in HEK293T cells identified two major sites
of ubiquitination, Lys-147 (K-Ras and H-Ras) and Lys-117
(H-Ras only) (28). Our data indicate that these modifications
result in Ras activation, but act through distinct mechanisms.
An additionalminor site of ubiquitinationwas observed at posi-
tion Lys-104 in K-Ras (28). Although Lys-147 and Lys-117 are
in a conserved nucleotide binding motif, Lys-104 is located in
helix 3 adjacent to the GEF binding interface (Fig. 2A). Substi-
tutions at this position (K104Q) have been proposed to alter
GEF-mediated dissociation by disrupting an electrostatic inter-
action that the Lys-104 side chain forms with the 2 helix.
Moreover, acetylation at this position has recently been shown
to impair GEF-mediated regulation of Ras (42). Therefore, we
FIGURE 2. Ras monoubiquitinated at lysine 104 retains the activity of unmodified Ras. A, structure of Ras-GDP (PDB 1CRR) with the Lys-104 side chain
highlighted in orange. Backbone residues in yellow make contact with the GEF Sos (PDB 1BKD), backbone residues in blue make contact with the GAP p120GAP
(PDB 1WQ1), and backbone residues in green are contacts common for both the GEF and the GAP. B, formation of disulfide bond between ubiquitinG76C and
RasK104C under nonreducing (NR) and reducing (R) conditions. The product of the reaction contains mUbRas, Ras, ubiquitin-ubiquitin dimer (Ub-Ub), and free
ubiquitin (Ub). C, the thermal stability of Ras (black squares throughout), RasK104C (orange triangles throughout), and mUbRasK104 (green circles throughout)
measured by fQCR. The data were normalized using the maximum fluorescence intensity. Results are the mean  S.E. (n  4). D, intrinsic nucleotide dissociation
(closed symbols) for Ras, RasK104C, and mUbRasK104 loaded with MANT-GDP. The rate of GDP dissociation was determined by monitoring the decrease in
MANT-GDP fluorescence emission over time following the addition of unlabeled GDP. Nucleotide dissociation was also measured in the presence of a 1:1 molar
ratio of Ras to Soscat (open symbols). Data were fit to an exponential dissociation curve, and the results are the mean  S.E. (n  4). E, single-turnover GTP
hydrolysis for Ras, RasK104C, and mUbRasK104 in the absence (closed symbols) and presence (open symbols) of GAP-334 (1:500 GAP:Ras). Hydrolysis was initiated
by the addition of Mg2 and monitored by the change in fluorescence of the protein, Flippi, upon binding free phosphate. Data were converted to a phosphate
concentration using a standard curve. Results are the mean  S.E. (n  6).
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considered whether monoubiquitination at Lys-104 could also
alter K-Ras activity.
To determine whether monoubiquitination at position 104
alters Ras activity, we chemically monoubiquitinated the pro-
tein at Lys-104 (mUbRasK104) (Fig. 2B) and measured thermal
stability as well as intrinsic and regulator-mediated enzymatic
activity. As seen in Fig. 2C, the thermal stability of mUbRasK104
is similar to that of Ras (Tm  50.8  0.4 °C), consistent with
mutation at this same position.Wenextmeasured intrinsic and
GEF-mediated rates of GDP dissociation using Soscat. This
analysis showed that nucleotide release was unaffected by
monoubiquitination or mutation at position 104 (Fig. 2D).
However, we did not observe a change in Soscat-mediated dis-
sociation formUbRasK104 (Fig. 2D), although the RasK104C sub-
stitution decreased Soscat-mediated activation by 5-fold, con-
sistent with previous studies (42). Neither monoubiquitination
normutation at position 104 altered intrinsic orGAP-mediated
single-turnover GTP hydrolysis (Fig. 2E). Together, these data
demonstrate that Lys-104 on Ras can be monoubiquitinated
without altering intrinsic or regulator-mediated activity.More-
over, although K-Ras can be ubiquitinated at two distinct
lysines in vivo (Lys-147 and Lys-104), only the more prevalent
site of ubiquitination, Lys-147, leads to a change in the active
state of the protein.
H-Ras Is Activated and Primarily Modified at Lysine 117
in HEK293T Cells—Our mechanistic studies indicate that
monoubiquitination of H-Ras at Lys-117 enhances guanine
nucleotide dissociation, leading to increased GTP loading and
protein activation. We previously showed that the mechanism
of K-Ras activation determined in vitro, using a chemical ubiq-
uitination approach, recapitulated the GAP defect observed for
mUbRasK147 in cell lysate assays (29). In the original study by
Sasaki et al. (28), H-Ras was found to be ubiquitinated at both
Lys-117 and Lys-147 in HEK293T cells. Because ubiquitination
at Lys-117 and Lys-147 activates Ras by distinct mechanisms,
we exploited this difference to determinewhethermodification
at one or the other lysines predominates in HEK293T cells.
Using Ras binding domain pulldown assays that specifically
detect GTP-bound Ras, we measured intrinsic and regulator-
mediated nucleotide exchange and hydrolysis. Monoubiquiti-
nated Ras accounts for 1% of the total Ras protein and was
detected by blotting for HA-ubiquitin. As seen in Fig. 3A, as the
concentration of exogenously added GDP increases, the popu-
lation ofGTP-boundmUbRas decreasesmore than unmodified
GTP-bound H-Ras. The increased loss of activated mUbRas
relative to unmodified Ras indicates that nucleotide exchange is
faster when H-Ras is monoubiquitinated. This result is similar
to what is observed in the RasK117R mutant (Fig. 3A), which has
previously been shown to possesses an 80-fold faster rate of
intrinsic nucleotide dissociation relative to unmodified Ras,
similar to the 70-fold increased rate of nucleotide exchange
observed for mUbRasK117 (41). We also determined whether
the population of monoubiquitinated H-Ras immunoprecipi-
tated fromHEK293T cell lysates was sensitive to Sos-mediated
regulation. When H-Ras is monoubiquitinated, the population
of active protein does not change significantly in the presence of
recombinant GEF (Fig. 3B), indicating that mUbRas is not fur-
ther activated by Soscat. Ras and mUbRas were equally respon-
sive to the addition of recombinant GAP-334, suggesting that
Ras had beenmodified at a site other than Lys-147 in these cells
(Fig. 3C). Based on these findings, we propose that cellular
H-Ras is predominately monoubiquitinated at Lys-117 in
FIGURE 3. Assays in cell lysate indicate H-Ras is primarily modified at lysine 117. A, immunoblotting of GTP-bound H-Ras, GTP-bound mUbRas, and
GTP-bound H-RasK117R from cell extracts in the presence of the indicated concentrations of GDP. Anti-FLAG and anti-HA antibodies reveal the relative fraction
of total Ras and mUbRas, respectively, for all assays. Molecular masses are shown in italics for all panels. B, immunoblotting of GTP-bound Ras and GTP-bound
mUbRas from cell extracts in the presence of the indicated concentrations of recombinant p120GAP, GAP-334. C, immunoblotting of GTP-bound Ras and
GTP-bound mUbRas in cell extract in the presence of increasing concentrations of recombinant Soscat and 25 M GTPS.
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HEK293T cells and that monoubiquitination at this site acti-
vates the protein through a mechanism distinct from that of
K-Ras. Although monoubiquitinated K-Ras is uncoupled from
the GTPase-activating protein, monoubiquitinated H-Ras
exhibits an increase in intrinsic nucleotide exchange activity.
DISCUSSION
We have shown previously that monoubiquitination of
K-Ras at Lys-147 promotes protein activation by rendering the
protein insensitive to GAP-mediated GTP hydrolysis (29). This
same modification does not alter the intrinsic nucleotide
exchange and GTP hydrolysis activities of Ras, and it has only a
modest effect on GEF-mediated nucleotide exchange. Here, we
characterize two additional sites of monoubiquitination, one
acting on K-Ras at Lys-104 and the other acting on H-Ras at
Lys-117. We find that in vitro, monoubiquitination at Lys-117
uniquely up-regulates H-Ras activity by promoting exchange of
GDP for GTP. Furthermore, our cell lysate assays indicate that
ubiquitination of H-Ras at Lys-117 predominates in HEK293T
cells because monoubiquitinated H-Ras was sensitive to GAP-
mediated regulation but displayed an increased rate of intrinsic
nucleotide exchange. Activation of Ras by sustained GTP bind-
ing (monoubiquitination ofK-Ras at Lys-147)mayhave distinct
cellular outcomes from that of constitutive GTP cycling
(monoubiquitination of H-Ras at Lys-117). In support of this
premise, disease-related Ras mutations that are activated
through increased exchange have different phenotypes than
those that cause inhibition of GAP-mediated hydrolysis (43).
In contrast tomonoubiquitination of Ras at Lys-147 and Lys-
117, monoubiquitination of Lys-104 does not affect Ras activity
in vitro. The absence of any functional difference is striking,
particularly because monoubiquitination at a nearby site (Lys-
117) was sufficient to fully activate the protein. Nevertheless,
the identification of amonoubiquitination site on Ras that does
not alter activity is consistent with previous data obtained in
CHOK-1 cells, where trafficking to the endosome rather than
direct H-Ras activation was the consequence of monoubiquiti-
nation (26). Together, these data suggest that site-specific ubiq-
uitinationmay occur in both an isoform-specific and a cell line-
specific manner to regulate Ras localization and signaling. Left
unresolved is how the differences in ubiquitination are con-
trolled, although they are likely to depend on differences in E3
ubiquitin ligase and deubiquitinating enzyme expression or
localization (28).
It was recently shown that Lys-104 is also a site of acetylation
in K-Ras in HEK293T cells (42). Molecular dynamics simula-
tions suggest that acetylation at Lys-104 alters switch II due to a
perturbation in electrostatic interaction in the 2 helix that
populates the Ras switch region in a disordered conformation,
which is less favorable for Ras-GEF interaction (42). Acetyla-
tion of K-Ras at Lys-104 conferred a defect in GEF-mediated
exchange, resulting in its accumulation in the inactive GDP-
bound state both in vitro and in cells (42).Given that acetylation
and monoubiquitination are likely to be mutually exclusive,
theremay be a role for Lys-104 ubiquitination in protecting Ras
from acetylation, or vice versa.
Ras proteins are well known to be activated by growth factor
receptors and by oncogenic mutations. Although the structure
and sequence of the three Ras isoforms are highly conserved,
they play distinct roles in signaling and cell regulation in vivo.
Differences in Ras localization and activity are driven by differ-
ences in post-translational modifications (12–19). Our analysis
has revealed two distinctmechanisms of Ras activation through
the same post-translational modification. Furthermore, our
biochemical analysis of site-specific Ras ubiquitination
revealed that ubiquitination alters Ras through mechanisms
distinct from mutations at the same positions. Assuming that
these events are regulated independently, our findings reveal a
potential new mechanism for dictating functional hierarchy
and conferring isoform-dependent differences in Ras activation
and signaling.
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